Randomized phase II study of platinum and etoposide (EP) versus temozolomide and capecitabine (CAPTEM) in patients (pts) with advanced G3 non-small cell gastroenteropancreatic neuroendocrine neoplasms (GEPNENs): ECOG-ACRIN EA2142 Meeting Abstract
| Authors: | Eads, J. R.; Catalano, P. J.; Fisher, G. A.; Rubin, D.; Iagaru, A.; Klimstra, D. S.; Konda, B.; Kwong, M. S.; Chan, J. A.; De Jesus-Acosta, A.; Halfdanarson, T. R.; Shaib, W. L.; Soares, H. P.; Hong, S. C.; Wong, T. Z.; O'Dwyer, P. J. |
| Abstract Title: | Randomized phase II study of platinum and etoposide (EP) versus temozolomide and capecitabine (CAPTEM) in patients (pts) with advanced G3 non-small cell gastroenteropancreatic neuroendocrine neoplasms (GEPNENs): ECOG-ACRIN EA2142 |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301186 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.4020 |
| Notes: | Meeting Abstract: 4020 -- This meeting was also held virtually -- Source: Wos |
